minimally invasive surgery

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.

Royal Philips coordinates seven clinical trials across Europe to validate AI-assisted robotics for brain and liver tumor treatments, addressing physician shortages.

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.

Rigid endoscopes market to grow from $7.36B to $11.52B by 2033, driven by minimally invasive surgery demand and technological advances in imaging capabilities.

Hemostasis products market expected to grow from $1.94B to $3.28B by 2035, driven by increased surgeries and trauma cases requiring advanced bleeding control solutions.

Fibrin sealant market to double from $1.60B to $3.57B by 2035, driven by surgical demand and minimally invasive techniques despite accessibility challenges in developing regions.